Patent Assignment
Reel/Frame 059788/0518
Assignment of Assignor's Interest
Recorded: 2022-04-25
Pages: 80
Assignor
TARVEDA THERAPEUTICS, INC.
Executed: 2022-04-15
Assignee
TVA (ABC), LLC
1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Covered Properties
(113)
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
14/144,263 →
Publication:
US 2014/0187501
Cabazitaxel-Platinum Nanoparticles and Methods of Using Same
Nanoparticle Diagnostic and Methods for Treating Disease
Application:
14/908,661 →
Publication:
US 2016/0166715
Sstr-Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
14/949,138 →
Publication:
US 2016/0074526
Targeted Therapeutics
Application:
15/314,769 →
Publication:
US 2017/0136085
Targeted Conjugates and Particles and Formulations Thereof
Application:
15/319,738 →
Publication:
US 2017/0151339
Targeted Conjugates and Particles and Formulations Thereof
Targeted Conjugates and Particles and Formulations Thereof
Targeted Conjugates and Particles and Formulations Thereof
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
15/695,214 →
Publication:
US 2018/0021454
Combination Therapy
Application:
15/734,110 →
Publication:
US 2021/0186978
Targeted Conjugates and Particles and Formulations Thereof
Application:
15/737,084 →
Publication:
US 2019/0125888
Compositions and Methods for Immuno-Oncology Therapies
Application:
15/749,180 →
Publication:
US 2018/0221503
Compositions and Methods for Immunomodulation
Application:
15/749,194 →
Publication:
US 2018/0221508
Compositions and Methods for Genome Editing
Application:
15/762,627 →
Publication:
US 2018/0258411
RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
Application:
15/762,635 →
Publication:
US 2018/0273948
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Targeted Constructs and Formulations Thereof
Application:
15/952,275 →
Publication:
US 2018/0296685
Stapled Peptide Conjugates and Particles
Application:
16/075,292 →
Publication:
US 2019/0365913
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Antibody Mimic Conjugates and Particles
Application:
16/085,398 →
Publication:
US 2019/0085034
Neurotensin Receptor Binding Conjugates and Formulations Thereof
Application:
16/093,233 →
Publication:
US 2020/0078468
Targeted Constructs and Formulations Thereof
Application:
16/301,144 →
Publication:
US 2020/0009262
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Nanoparticle Diagnostic and Methods for Treating Disease
Application:
16/381,332 →
Publication:
US 2019/0231906
HSP90-Targeting Conjugates and Formulations Thereof
Targeted Therapeutics
Application:
16/625,358 →
Publication:
US 2020/0230126
Combination Therapies Comprising Targeted Therapeutics
Application:
16/625,362 →
Publication:
US 2020/0230247
HSP90 Targeted Conjugates and Particle Formulations Thereof
Application:
16/625,368 →
Publication:
US 2020/0237746
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Sstr-Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
16/722,913 →
Publication:
US 2020/0121808
Sstr-Targeted Conjugates and Formulations Thereof
Application:
16/759,438 →
Publication:
US 2020/0281934
HSP90-Targeting Conjugates and Formulations Thereof
Application:
16/772,290 →
Publication:
US 2021/0000966
Targeted Conjugates and Particles and Formulations Thereof
RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
Application:
16/921,390 →
Publication:
US 2020/0339990
HSP90-Targeting Conjugates and Formulations Thereof
Application:
17/045,320 →
Publication:
US 2021/0145971
Pharmaceutical Compositions with Reduced Tert-Butanol Levels
Application:
17/045,325 →
Publication:
US 2021/0169871
HSP90-Targeting Conjugates and Formulations Thereof
Application:
17/275,748 →
Publication:
US 2022/0031853
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
17/490,692 →
Publication:
US 2022/0096646
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
17/518,794 →
Publication:
US 2022/0054647
HSP90-Targeting Conjugates and Formulations Thereof
Application:
17/546,706 →
Publication:
US 2022/0096640
HSP90-Binding Conjugates and Formulations Thereof
Application:
17/600,692 →
Publication:
US 2022/0184217
Sstr-Targeted Conjugates and Formulations Thereof
Application:
17/618,759 →
Publication:
US 2022/0257766
HSP90-Binding Conjugates and Combination Therapies Thereof
Application:
17/618,761 →
Publication:
US 2022/0257777
Nanoparticulate Targeted Drug Delivery
Application:
61/746,866 →
Cabazitaxel-Platinum Nanoparticles and Methods of Using Same
Application:
61/792,665 →
Nanoparticle Diagnostic and Methods for Treating Disease
Application:
61/859,826 →
Targeted Therapeutics
Application:
62/004,519 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
62/019,001 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
62/019,003 →
Particles Incorporating Drug Conjugates of Targeting Scaffolds and Formulations Thereof
Application:
62/020,615 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
62/077,487 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application:
62/084,306 →
Targeted Conjugates and Particles and Formulations Thereof
Application:
62/102,261 →
Targeted Conjugates and Particles and Formulations Thereof
Application:
62/150,413 →
Targeted Conjugates and Particles and Formulations Thereof
Application:
62/186,657 →
Compositions and Methods for Immuno-Oncology Therapies
Application:
62/199,414 →
Compositions and Methods for Immunomodulation
Application:
62/199,422 →
RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
Application:
62/232,627 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
62/247,336 →
Stapled Peptide Conjugates and Particles
Application:
62/291,212 →
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application:
62/298,917 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
62/304,856 →
Antibody Mimic Conjugates and Particles
Application:
62/308,908 →
Conjugates of Biased Agonists and Particles and Formulations Thereof
Application:
62/322,173 →
Compositions and Methods for Immuno-Oncology Therapies
Application:
62/332,772 →
Compositions and Methods for Immunomodulation
Application:
62/332,838 →
Targeted Constructs and Formulations Thereof
Application:
62/336,120 →
Penicillamine Conjugates and Particles and Formulations Thereof
Application:
62/343,445 →
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application:
62/351,716 →
T Cell Binding Conjugates and Methods of Use
Application:
62/368,632 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
62/414,481 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/434,282 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/449,260 →
Targeted Constructs and Formulations Thereof
Application:
62/476,123 →
Neurotensin Conjugates and Formulations Thereof
Application:
62/476,132 →
Targeted Constructs and Formulations Thereof
Application:
62/485,064 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/487,726 →
Fcrn-Binding Antibody Mimetics and Targeted Constructs
Application:
62/513,842 →
Antibody Mimetics and Targeted Constructs
Application:
62/513,882 →
Targeted Therapeutics
Application:
62/522,316 →
Combination Therapies Comprising Targeted Therapeutics
Application:
62/522,323 →
HSP90 Targeted Conjugates and Particle Formulations Thereof
Application:
62/522,333 →
Targeted Constructs
Application:
62/535,347 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application:
62/577,897 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/598,755 →
Targeted Constructs
Application:
62/599,352 →
Targeted Therapeutics
Application:
62/642,154 →
Targeted Constructs
Application:
62/653,093 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/653,106 →
Pharmaceutical Compositions with Reduced Tert-Butanol Levels
Application:
62/653,118 →
Combination Therapy
Application:
62/679,216 →
Combination Therapies Comprising Targeted Therapeutics
Application:
62/679,224 →
Sstr-Targeted Conjugates and Formulations Thereof
Application:
62/679,230 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/684,666 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/731,538 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/731,543 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/731,545 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/735,306 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/757,955 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/787,799 →
Combination Therapy
Application:
62/788,326 →
Combination Therapy
Application:
62/827,232 →
HSP90-Targeting Conjugates and Formulations Thereof
Application:
62/828,645 →
Sstr-Targeted Conjugates and Formulations Thereof
Application:
62/866,134 →
HSP90-Binding Conjugates and Combination Therapies Thereof
Application:
62/866,140 →
Targeted Therapeutics
Application:
62/899,777 →
HSP90-Binding Conjugates and Formulations Thereof
Application:
62/986,245 →
HSP90-Binding Conjugates and Formulations Thereof
Application:
63/003,528 →
HSP90-Binding Conjugates and Combination Therapies Thereof
Application:
63/035,048 →
HSP90-Binding Conjugates and Formulations Thereof
Application:
63/070,418 →
HSP90-Binding Conjugates and Formulations Thereof
Application:
63/184,348 →
HSP90-Binding Conjugates and Formulations Thereof
Application:
63/184,352 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 14, 2014
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 032663/0189 →
Assignment of Assignor's Interest
Jul 8, 2014
From: BILODEAU, MARK T.; DUNBAR, CRAIG A.; BARDER, TIMOTHY E.; LEE, EDWARD R.
To: BLEND THERAPEUTICS
Reel/Frame 033262/0769 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 033262 Frame: 0769. Assignor(S) Hereby Confirms the Assignment.
Apr 16, 2015
From: BILODEAU, MARK T.; DUNBAR, CRAIG A.; BARDER, TIMOTHY E.; LEE, EDWARD R.
To: BLEND THERAPEUTICS, INC.
Reel/Frame 035444/0319 →
Assignment of Assignor's Interest
Jan 21, 2016
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 037545/0592 →
Change of Name
Jan 28, 2016
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 037629/0907 →
Assignment of Assignor's Interest
Feb 1, 2016
From: KADIYALA, SUDHAKAR; LIM SOO, PATRICK; IWICKI, MARK; DUNBAR, CRAIG
To: BLEND THERAPEUTICS, INC.
Reel/Frame 037632/0062 →
Change of Name
Feb 2, 2016
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 037680/0907 →
Change of Name
Jan 11, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 041343/0936 →
Assignment of Assignor's Interest
Jan 11, 2017
From: WHITE, BRIAN H.; ALARGOVA, ROSSITZA G.; BAZINET, PATRICK ROSAIRE; DUNBAR, CRAIG A.
To: BLEND THERAPEUTICS, INC.
Reel/Frame 041343/0882 →
Change of Name
Jan 26, 2017
From: SYNTA PHARMACEUTICALS CORP.
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 041511/0666 →
Assignment of Assignor's Interest
Jan 26, 2017
From: CHEN, SHOUJUN; LU, GENLIANG; OSMAN, SAMI
To: SYNTA PHARMACEUTICALS CORP.
Reel/Frame 041097/0973 →
Assignment of Assignor's Interest
Apr 10, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 041948/0908 →
Change of Name
Apr 10, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 042201/0282 →
Change of Name
Jul 20, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 043269/0688 →
Change of Name
Jul 20, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 043269/0617 →
Assignment of Assignor's Interest
Jul 20, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043052/0964 →
Assignment of Assignor's Interest
Jul 20, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043052/0879 →
Change of Name
Sep 6, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 043762/0299 →
Assignment of Assignor's Interest
Sep 6, 2017
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043495/0338 →
Assignment of Assignor's Interest
Nov 7, 2017
From: MOREAU, BENOÎT
To: BLEND THERAPEUTICS, INC.
Reel/Frame 044055/0331 →
Change of Name
Nov 7, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 044392/0474 →
Change of Name
Nov 8, 2017
From: BLEND THERAPEUTICS, INC
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 044722/0971 →
Assignment of Assignor's Interest
Nov 8, 2017
From: MOREAU, BENOÎT
To: BLEND THERAPEUTICS, INC.
Reel/Frame 044073/0959 →
Assignment of Assignor's Interest
Jan 9, 2018
From: WHITE, BRIAN H.; BILODEAU, MARK T.; MOREAU, BENOÎT; SHINDE, RAJESH R.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 044574/0772 →
Assignment of Assignor's Interest
Jan 31, 2018
From: KADIYALA, SUDHAKAR; WARD, DONNA T.; WOOSTER, RICHARD
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 044782/0052 →